After 48 weeks of treatment, the results were: -2.1% for the placebo group, -8.7% for the 1 mg group, -17.1% for the combined 4 mg group, -22.8% for the combined 8 mg group, and -24.2% for the 12 mg group
When ARA-290 binds to the IRR, it does two critical things: It shuts down inflammation: It tells the immune system to stop attacking the damaged area, switching the focus from "defense" to "reconstruction." It stimulates regeneration: It promotes the sprouting of small nerve fibers, which are often the first to die in conditions like Small Fiber Neuropathy (SFN)
The company has consistently ranked among the top 100 global pharmaceutical companies and is recognized as one of the top 3 pharmaceutical R&D enterprises in China, and is designated as a National Key High-Tech Enterprise and a National Technology Innovation Demonstration Enterprise
Within a week after taking a dose, uric acid is significantly lowered by allopurinol